China FDA accepts Eisai additional application on Aricept for Alzheimer's; Beijing cracks down on food and drug crimes;

> China FDA accepted an application from Japan's Eisai on additional indication of Aricept for severe Alzheimer's disease. Release

> China launched a crackdown on food and drug crimes. Release

> Japan's Eisai got a boost following news of clinical trial collaboration with Merck ($MRK) on Keytruda cancer treatment. Release (PDF)

> Japan's Ono Pharmaceutical got a U.S. FDA nod on Opdivo co-developed with Bristol-Myers Squibb ($BMY) as a lung-cancer treatment. Release (PDF)

Read more on